Research priorities in biomarkers and surrogate end-points (Q36081463)

12 August 2017

Research priorities in biomarkers and surrogate end-points (English)

1 reference

12 August 2017

0 references

1 reference

1

Jeffrey K Aronson

1 reference

PMCID

3391516

12 August 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

British Journal of Clinical Pharmacology

12 August 2017

1 reference

12 August 2017

73

1 reference

12 August 2017

6

1 reference

12 August 2017

900-907

1 reference

Developing and delivering clinical toxicology in the UK National Health Service

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Biomarkers and surrogate endpoints

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia. 1983.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Analytic aspects of monitoring therapy with thiopurine medications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Strategies for developing biomarkers of heart failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Paracetamol overdose: an evidence based flowchart to guide management

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

When can a risk factor be used as a worthwhile screening test?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Nonresolving or slowly resolving pneumonia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Surrogate endpoints in clinical trials: definition and operational criteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

The role of tumour markers in ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

ABC of monitoring drug therapy. Cyclosporin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Evidence-based mechanistic reasoning.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Surrogate endpoints in clinical trials: cardiovascular diseases.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Whose TPMT activity is it anyway?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3391516

Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22360291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of treatment with beclomethasone, cromoglycate and theophylline on perception of bronchoconstriction in patients with bronchial asthma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22360291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2012.04234.X

1 reference

release_mole5zwjxbdu5cvuqqh4fh2ule

12 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mole5zwjxbdu5cvuqqh4fh2ule

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

3391516

1 reference

12 August 2017

1 reference

PMCID

3391516